CEO Today USA Awards

www.ceotodaymagazine.com 78 CEO Today USAAwards 2018 MASSACHUSETTS ROBERT FRIEL Chairman, President & CEO of PerkinElmer ABOUT ROBERT FRIEL Mr. Friel currently serves as Chairman, Chief Executive Officer and President of PerkinElmer. Prior to being appointed President and Chief Executive Officer in February 2008 and Chairman in April 2009, he had served as President and Chief Operating Officer since August 2007, and as Vice Chairman and President of our Life and Analytical Sciences unit since January 2006. Mr. Friel was our Executive Vice President and Chief Financial Officer, with responsibility for business development and information technology in addition to his oversight of our finance functions, from October 2004 until January 2006. Mr. Friel joined PerkinElmer in February 1999 as our Senior Vice President and Chief Financial Officer. Prior to joining PerkinElmer, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University. Mr. Friel currently serves on the board of directors of NuVasive, Inc. and Xylem Inc. He also previously served on the national board of trustees for the March of Dimes Foundation. Mr. Friel has been one of the primary architects of PerkinElmer’s transformation into a global technology leader focused on innovating for a healthier world. Mr. Friel’s eighteen years of executive experience with PerkinElmer has allowed him to develop a broad knowledge of our operations and activities, and that operational and leadership experience has been essential in formulating appropriate business strategies. His current and past service on the boards of other public companies has provided him with additional insights about service as the Chairman of our board. www.perkinelmer.com FIRM PROFILE Imagine a world where you could detect health issues sooner to treat them more effectively. Where food and water are always safe, even in remote corners of the earth. And where scientific and medical research are enhanced to solve the greatest challenges of our times. At PerkinElmer, we imagine this world every day. Then, we innovate and collaborate to make it happen everywhere. With over 11,400 employees around the globe, we pioneer scientific technologies for better detection, imaging, and informatics to help our customers make a profound impact on the world. We provide support with advanced services to ensure optimal operations. Innovating to Unlock Critical Insights That Make an Impact PerkinElmer’s commitment to scientific innovation is at the heart of everything we do. It is why our customers turn to us to help them unlock critical insights that make impacts: smarter decisions, earlier diagnoses, more effective treatments and scientific breakthroughs. We serve as a true strategic partner, first understanding customers’ most pressing business challenges and then developing innovations to meet those needs, or working collaboratively with customers to jointly discover breakthroughs. With our over 3,500 patents and counting, global network of R&D centers of excellence and market- leading detection, imaging, and informatics innovations, PerkinElmer provides an unmatched experience that enables customers to better protect our environment, food supply and health of our families. Together, we are making a difference for the better: For more effective drugs: PerkinElmer technologies and expertise were instrumental in the development of 22 novel therapeutic drugs. For healthier babies: Our neonatal and newborn screening technologies have aided in screening over 600 million babies worldwide for a variety of life- threatening diseases, helping them get a healthier start. For a cleaner and safer environment: Our instrumentation and solutions test 289 billion gallons of water a year to provide safe drinking water for 1 billion people. For a safer food supply: In 2017, we analyzed 220 million tons of wheat for quality within the global grain supply chain. For more informed scientific decisions: Deploying Spotfire licenses across more than 300 enterprises so researchers can better capture and visualize insights. For greater efficiencies: Our OneSource services team manages assets in over 8,000 labs around the world.